1. The National Burden of Colorectal Cancer in the United States from 1990 to 2019.
- Author
-
Alsakarneh, Saqr, Jaber, Fouad, Beran, Azizullah, Aldiabat, Mohammad, Abboud, Yazan, Hassan, Noor, Abdallah, Mohamed, Abdelfattah, Thaer, Numan, Laith, Clarkston, Wendell, Bilal, Mohammad, and Shaukat, Aasma
- Subjects
HEALTH policy ,CANCER patient psychology ,TIME ,AGE distribution ,DISEASE incidence ,POPULATION geography ,COLORECTAL cancer ,SEX distribution ,DISEASE prevalence ,ECONOMIC aspects of diseases ,HEALTH equity ,HEALTH care rationing ,DISEASE risk factors - Abstract
Simple Summary: Colorectal cancer (CRC) is a significant global health concern, ranking as the second leading cause of cancer-related deaths. Despite an overall decline in CRC rates in the United States, there is a concerning rise in early-onset cases (diagnosed before age 50). This study, utilizing comprehensive data from the Global Burden of Disease 2019, delves into the state-specific trends in CRC incidence, prevalence, and mortality over three decades (1990–2019). Notably, the research reveals varying patterns across geographic regions, gender, and age groups. Understanding these nuanced trends is crucial for targeted resource allocation and policy decisions to effectively combat CRC, a disease with an increasing impact on younger adults in the United States. CRC accounts for approximately a tenth of all cancer cases and deaths in the US. Due to large differences in demographics among the different states, we aim to determine trends in the CRC epidemiology and across different states, age groups, and genders. CRC rates, age-adjusted to the standard US population, were obtained from the GBD 2019 database. Time trends were estimated as annual percentage change (APC). A pairwise comparison was conducted between age- and gender-specific trends using the tests of parallelism and coincidence. Age-specific trends were also assessed in two age subgroups: younger adults aged 15–49 years and older adults aged 50–74 years. We also analyzed the prevalence, incidence, mortality, and DALYs in the US between 1990 and 2019. A total of 5.53 million patients were diagnosed with CRC in the US between 1990 and 2019. Overall, CRC incidence rates have significantly increased in younger adults (11.1 per 100,000 persons) and decreased in older adults (136.8 per 100,000 persons) (AAPC = 1.2 vs. −0.6; AAPC difference = 1.8, p < 0.001). Age-specific trends were neither identical (p < 0.001) nor parallel (p < 0.001), suggesting that CRC incidence rates are different and increasing at a greater rate in younger adults compared to older adults. However, for both men and women (49.4 and 35.2 per 100,000 persons), incidence rates have decreased over the past three decades at the same rate (AAPC = −0.5 vs. −0.5; AAPC difference = 0, p = 0.1). Geographically, the southern states had the highest mortality rates with Mississippi having the highest rate of 20.1 cases per 100,000 population in 2019. Massachusetts, New York, and the District of Colombia had the greatest decreases in mortality over the study period (−42.1%, −41.4%, and −40.9%). Decreased mortality was found in all states except Mississippi, where the mortality of CRC increased over the study period (+1.5%). This research provides crucial insights for policymakers to tailor resource allocation, emphasizing the dynamic nature of CRC burden across states and age groups, ultimately informing targeted strategies for prevention and intervention. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF